Irish Patients Wait Three Times As Long For Same Medicines Available In Other European Countries

‘Innovate For Life’ Conference hears:

  • Patients in Ireland wait an average of 843 days for 15 new medicines, against 289 days for patients in 14 ‘reference’ countries in Europe
  • Five of the 15 medicines are either fully or partially made in Ireland
  • Nine of the 15 medicines are for cancer 
  • Explicit ‘Medicines Policy’ needed to fix access and funding problems
  • Partnership lessons learned through Brexit preparation can be applied in other ways

 

Read more

Seven In 10 People ‘Trust’ Vaccines, says Ipsos MRBI Survey For IPHA

New research, released at IPHA’s ‘Innovate for Life Conference’, shows:

  • ‘Worrying’ levels of uncertainty, especially among over-55s, about vaccines’ effectiveness 
  • Lack of information is the biggest barrier to childhood vaccination

Read more

IPHA Backs Call For More Patient Involvement In Evaluating New Treatments

Patients should have a greater say in the evaluation of new treatments, according to the Irish Pharmaceutical Healthcare Association (IPHA), the representative organisation for the originator pharmaceutical industry.

Read more

Campaign urges public to visit their pharmacy to manage winter illnesses

The public is being urged to work with their pharmacist to tackle illnesses that are more prevalent in winter such as coughs and colds. The Irish Pharmaceutical Healthcare Association (IPHA) and the Irish Pharmacy Union (IPU) are making the call in a newly launched self care awareness campaign, entitled ‘Be Well this this Winter – Think Pharmacy’

Read more

IPHA Conference To Make Big Statement About The Future For Medicines Innovation

More than 300 delegates will gather in Croke Park, Dublin, this month for ‘Innovate for Life’, the IPHA Annual Conference and Dinner which is set to make a big statement about the future for medicines innovation.

The event will draw record numbers across industry, policy, patient advocacy, research and academia for lively discussions on the major themes shaping the biopharmaceutical industry in Ireland and globally.

 

Read more

'Brexit Budget' must not further delay new medicines for patients, says IPHA

As health budget rises by €1bn, an ‘adequate allocation’ for new medicines is vital

Read more

IPHA urges new Trade Commissioner to back IP protection in Europe

The new EU Trade Commissioner, Phil Hogan, has been urged to protect and strengthen biopharmaceutical intellectual property (IP) incentives as part of his growth plans for Europe’s economy.

 

Read more